Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels
Objective: Drug eluting stent (DES) could result in both in-stent restenosis and high bleeding risk due to long-term anti-platelet therapy. Drug-coated balloon (DCB) delivers anti-proliferative drugs without implanting metal into vascular wall. Our aim was to investigate its feasibility in large ves...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Indian Heart Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483225000616 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689227296505856 |
|---|---|
| author | Hesham Refaat Mohamed Arab |
| author_facet | Hesham Refaat Mohamed Arab |
| author_sort | Hesham Refaat |
| collection | DOAJ |
| description | Objective: Drug eluting stent (DES) could result in both in-stent restenosis and high bleeding risk due to long-term anti-platelet therapy. Drug-coated balloon (DCB) delivers anti-proliferative drugs without implanting metal into vascular wall. Our aim was to investigate its feasibility in large vessel coronary artery disease (LvCAD), compared to small vessel coronary artery disease (SvCAD). Methods: This study enrolled 237 patients with de novo coronary lesions treated with DCB-only strategy and categorized according to the reference vessel diameter of 3 mm into SvCAD and LvCAD groups. The primary endpoint was in-lesion late lumen loss (LLL). The secondary endpoints included composite major adverse cardiac events (MACE), cardiac death, non-fatal myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), and vessel thrombosis. Results: The immediate (3.06 ± 0.25 vs. 2.33 ± 0.21 mm, p = 0.001) and follow up minimal lumen diameter (3.13 ± 0.25 vs. 2.41 ± 0.21 mm, p = 0.001) and acute gain (1.92 ± 0.29 vs. 1.5 ± 0.26 mm, p = 0.04) were significantly higher in LvCAD group. In-lesion LLL was negative without significant difference (-0.07 ± 0.02 vs. - 0.06 ± 0.04 mm, p = 0.69). The incidence of adverse clinical events was not statistically significant accounting for 6.5 % vs. 10.5 % for composite MACE (p = 0.27), 0.8 % vs. 0.9 % for cardiac death (p = 0.96), 4.9 % vs.7 % for non-fatal MI (p = 0.49), 4.1 % vs. 6.1 % for TLR (p = 0.47), 2.4 % vs. 3.5 % for TVR (p = 0.63) and 1.6 % vs. 2.6 % for vessel thrombosis (p = 0.59). Conclusion: DCB-only strategy is effective in treating LvCAD with comparable outcomes to SvCAD. |
| format | Article |
| id | doaj-art-8da75dd19d2643dcb75bc22fba5a73b6 |
| institution | DOAJ |
| issn | 0019-4832 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Indian Heart Journal |
| spelling | doaj-art-8da75dd19d2643dcb75bc22fba5a73b62025-08-20T03:21:42ZengElsevierIndian Heart Journal0019-48322025-05-0177317418110.1016/j.ihj.2025.03.015Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vesselsHesham Refaat0Mohamed Arab1Corresponding author.; Cardiology Department, Zagazig University, Zagazig, EgyptCardiology Department, Zagazig University, Zagazig, EgyptObjective: Drug eluting stent (DES) could result in both in-stent restenosis and high bleeding risk due to long-term anti-platelet therapy. Drug-coated balloon (DCB) delivers anti-proliferative drugs without implanting metal into vascular wall. Our aim was to investigate its feasibility in large vessel coronary artery disease (LvCAD), compared to small vessel coronary artery disease (SvCAD). Methods: This study enrolled 237 patients with de novo coronary lesions treated with DCB-only strategy and categorized according to the reference vessel diameter of 3 mm into SvCAD and LvCAD groups. The primary endpoint was in-lesion late lumen loss (LLL). The secondary endpoints included composite major adverse cardiac events (MACE), cardiac death, non-fatal myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), and vessel thrombosis. Results: The immediate (3.06 ± 0.25 vs. 2.33 ± 0.21 mm, p = 0.001) and follow up minimal lumen diameter (3.13 ± 0.25 vs. 2.41 ± 0.21 mm, p = 0.001) and acute gain (1.92 ± 0.29 vs. 1.5 ± 0.26 mm, p = 0.04) were significantly higher in LvCAD group. In-lesion LLL was negative without significant difference (-0.07 ± 0.02 vs. - 0.06 ± 0.04 mm, p = 0.69). The incidence of adverse clinical events was not statistically significant accounting for 6.5 % vs. 10.5 % for composite MACE (p = 0.27), 0.8 % vs. 0.9 % for cardiac death (p = 0.96), 4.9 % vs.7 % for non-fatal MI (p = 0.49), 4.1 % vs. 6.1 % for TLR (p = 0.47), 2.4 % vs. 3.5 % for TVR (p = 0.63) and 1.6 % vs. 2.6 % for vessel thrombosis (p = 0.59). Conclusion: DCB-only strategy is effective in treating LvCAD with comparable outcomes to SvCAD.http://www.sciencedirect.com/science/article/pii/S0019483225000616Adverse outcomesCoronary lesionsDrug coated balloonDrug eluting stent |
| spellingShingle | Hesham Refaat Mohamed Arab Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels Indian Heart Journal Adverse outcomes Coronary lesions Drug coated balloon Drug eluting stent |
| title | Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels |
| title_full | Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels |
| title_fullStr | Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels |
| title_full_unstemmed | Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels |
| title_short | Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels |
| title_sort | efficacy and long term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels |
| topic | Adverse outcomes Coronary lesions Drug coated balloon Drug eluting stent |
| url | http://www.sciencedirect.com/science/article/pii/S0019483225000616 |
| work_keys_str_mv | AT heshamrefaat efficacyandlongtermoutcomesofdrugcoatedballoonindenovolesionsofsmallversuslargecoronaryvessels AT mohamedarab efficacyandlongtermoutcomesofdrugcoatedballoonindenovolesionsofsmallversuslargecoronaryvessels |